MiniMed Group Inc (NASDAQ:MMED) Stock Has Consensus Target Price of $23.77

Posted by Brian Himes on Sep 29th, 2026

Shares of MiniMed Group Inc (NASDAQ:MMED – Get Free Report) have been given a consensus rating of “Moderate Buy” by the seventeen ratings firms that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation and fourteen have assigned a buy recommendation to the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $24.14.

MMED has been the subject of several research analyst reports. Weiss Ratings upgraded shares of MiniMed Group from a “sell (d-)” rating to a “sell (d)” rating in a report on Wednesday, September 9th. Bank of America raised their price target on shares of MiniMed Group from $24.00 to $28.00 and gave the company a “buy” rating in a research note on Wednesday, September 2nd. BTIG Research boosted their price objective on shares of MiniMed Group from $25.00 to $28.00 and gave the stock a “buy” rating in a research note on Tuesday, September 1st. Morgan Stanley increased their price objective on MiniMed Group from $19.00 to $21.00 and gave the company an “overweight” rating in a report on Thursday, September 3rd. Finally, Truist Financial started coverage on MiniMed Group in a research report on Thursday, September 24th. They set a “buy” rating and a $29.00 target price for the company.

View Our Latest Stock Report on MMED

MiniMed Group Trading Up 2.6%

Shares of NASDAQ MMED opened at $20.49 on Tuesday. The stock has a 50-day moving average price of $20.21 and a two-hundred day moving average price of $16.23. The company has a market cap of $5.76 billion and a price-to-earnings ratio of -30.13. MiniMed Group has a 12 month low of $10.65 and a 12 month high of $24.43.

Hedge Funds Weigh In On MiniMed Group

A number of hedge funds have recently bought and sold shares of MMED. State Street Corp acquired a new stake in MiniMed Group during the 2nd quarter worth about $6,029,000. The Manufacturers Life Insurance Company bought a new position in MiniMed Group during the second quarter worth $185,000. WINTON GROUP Ltd bought a new position in shares of MiniMed Group during the 2nd quarter worth about $273,000. Engineers Gate Manager LP acquired a new stake in MiniMed Group in the second quarter valued at approximately $513,000. Finally, Squarepoint Ops LLC acquired a new stake in MiniMed Group in the 2nd quarter valued at $403,000.

MiniMed Group Company Profile

(Get Free Report)

We are a scaled global medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Since our founding more than 40 years ago, we have pioneered groundbreaking innovation and served the needs of our customers across the globe in service of our mission to make every day a better day for people with diabetes. Today, we are the only player in the market that commercializes all parts of an integrated diabetes management system.